» Articles » PMID: 8235659

Bcl-2 Inhibition of Neural Death: Decreased Generation of Reactive Oxygen Species

Overview
Journal Science
Specialty Science
Date 1993 Nov 19
PMID 8235659
Citations 267
Authors
Affiliations
Soon will be listed here.
Abstract

The proto-oncogene bcl-2 inhibits apoptotic and necrotic neural cell death. Expression of Bcl-2 in the GT1-7 neural cell line prevented death as a result of glutathione depletion. Intracellular reactive oxygen species and lipid peroxides rose rapidly in control cells depleted of glutathione, whereas cells expressing Bcl-2 displayed a blunted increase and complete survival. Modulation of the increase in reactive oxygen species influenced the degree of cell death. Yeast mutants null for superoxide dismutase were partially rescued by expression of Bcl-2. Thus, Bcl-2 prevents cell death by decreasing the net cellular generation of reactive oxygen species.

Citing Articles

The role of short-chain fatty acids in cancer prevention and cancer treatment.

Kalyanaraman B, Cheng G, Hardy M Arch Biochem Biophys. 2024; 761:110172.

PMID: 39369836 PMC: 11784870. DOI: 10.1016/j.abb.2024.110172.


A 70% Ethanol Extract Attenuates RANKL-Induced Osteoclast Activation and HO-Induced Osteoblast Apoptosis In Vitro.

Jeong S, Kim I, Moon H, Kim H, Song B, Choi J Molecules. 2024; 29(8).

PMID: 38675559 PMC: 11052068. DOI: 10.3390/molecules29081741.


Platelet-rich plasma (PRP) in nerve repair.

Wang S, Liu Z, Wang J, Cheng L, Hu J, Tang J Regen Ther. 2024; 27:244-250.

PMID: 38586873 PMC: 10997806. DOI: 10.1016/j.reth.2024.03.017.


Cell-specific modulation of mitochondrial respiration and metabolism by the pro-apoptotic Bcl-2 family members Bax and Bak.

Sovilj D, Kelemen C, Dvorakova S, Zobalova R, Raabova H, Kriska J Apoptosis. 2023; 29(3-4):424-438.

PMID: 38001340 DOI: 10.1007/s10495-023-01917-2.


Synthesis, DFT Study, and In Vitro Evaluation of Antioxidant Properties and Cytotoxic and Cytoprotective Effects of New Hydrazones on SH-SY5Y Neuroblastoma Cell Lines.

Tzankova D, Kuteva H, Mateev E, Stefanova D, Dzhemadan A, Yordanov Y Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765006 PMC: 10537553. DOI: 10.3390/ph16091198.